From: Cam J Martinez [camiz@juno.com]
Sent: Sunday, March 04, 2001 12:26 AM
To: fdadockets@oc.fda.gov
Subject: Public has a Right to Know

Dear FDA ~ 

**This proposed rule only brings gene therapy and xenotransplantation in
compliance with the same types of information already released to the
public by other government agencies.

**Because of the grave public health risks, disclosure should include
additional information such as names of physicians conducting the trials
and
names of participating medical centers. All information should be made
public except trade secrets and patient identification.

**The FDA must assume the sole responsibility for summarizing and
distributing information submitted by the research sponsors, rather than
leave it to the sponsors' discretion.

**Because of the public health risks, legal and ethical issues, enormous
cost, serious animal welfare concerns, and the failure to adequately
assess
other alternatives, all xenotransplantation clinical trials should stop.
Moreover, the U.S. government should stop funding xenotransplantation
research.

I don't want my tax dollars wasted on animal research of any type.

Thanks for your consideration.

Cam Martinez
San Diego, CA